PE20061314A1 - Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo - Google Patents
Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismoInfo
- Publication number
- PE20061314A1 PE20061314A1 PE2006000399A PE2006000399A PE20061314A1 PE 20061314 A1 PE20061314 A1 PE 20061314A1 PE 2006000399 A PE2006000399 A PE 2006000399A PE 2006000399 A PE2006000399 A PE 2006000399A PE 20061314 A1 PE20061314 A1 PE 20061314A1
- Authority
- PE
- Peru
- Prior art keywords
- artemisinin
- malaria
- derivative
- treatment
- ferroquine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
SE REFIERE A UNA COMPOSICION FARMACEUTICA QUE COMPRENDE: A) FERROQUINA EN FORMA DE BASE LIBRE CARACTERIZADA POR UNA DOSIS DIARIA COMPRENDIDA ENTRE 50 Y 1600 mg; B) DERIVADO DE ARTEMISININA TAL COMO ARTESUNATO O ARTEMETER COMPRENDIDA EN UNA DOSIS DIARIA ENTRE 1-10 mg/Kg/DIA. DICHA COMPOSICION SE ADMINISTRA DURANTE UN PERIODO DE 2-4 DIAS CONSECUTIVOS Y ES DE ADMINISTRACION ORAL, RECTAL O INYECTABLE, SIENDO UTILES EN EL TRATAMIENTO DE PALUDISMO
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0503932A FR2884715B1 (fr) | 2005-04-20 | 2005-04-20 | Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20061314A1 true PE20061314A1 (es) | 2006-12-27 |
Family
ID=35385843
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2010000537A PE20110119A1 (es) | 2005-04-20 | 2006-04-17 | Asociacion entre ferroquina y artesunato para el tratamiento del paludismo |
PE2006000399A PE20061314A1 (es) | 2005-04-20 | 2006-04-17 | Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2010000537A PE20110119A1 (es) | 2005-04-20 | 2006-04-17 | Asociacion entre ferroquina y artesunato para el tratamiento del paludismo |
Country Status (30)
Country | Link |
---|---|
US (1) | US20120258945A1 (es) |
EP (1) | EP1874293A1 (es) |
JP (1) | JP5148478B2 (es) |
KR (1) | KR20080009088A (es) |
CN (2) | CN101163470A (es) |
AP (1) | AP2782A (es) |
AR (1) | AR054253A1 (es) |
AU (1) | AU2006238506B2 (es) |
BR (1) | BRPI0610851A2 (es) |
CA (1) | CA2605385A1 (es) |
CR (1) | CR9425A (es) |
DO (1) | DOP2006000092A (es) |
EA (1) | EA012630B1 (es) |
FR (1) | FR2884715B1 (es) |
GT (1) | GT200600157A (es) |
HN (1) | HN2006015130A (es) |
IL (1) | IL186048A0 (es) |
MA (1) | MA29451B1 (es) |
MX (1) | MX2007012645A (es) |
MY (1) | MY145581A (es) |
NO (1) | NO20075920L (es) |
NZ (1) | NZ562117A (es) |
PA (1) | PA8669801A1 (es) |
PE (2) | PE20110119A1 (es) |
SG (1) | SG161270A1 (es) |
TN (1) | TNSN07359A1 (es) |
TW (1) | TWI387456B (es) |
UA (1) | UA96414C2 (es) |
WO (1) | WO2006111647A1 (es) |
ZA (1) | ZA200708800B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2926993B1 (fr) * | 2008-02-06 | 2011-03-11 | Sanofi Aventis | Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme |
FR2952823B1 (fr) * | 2009-10-30 | 2012-04-20 | Sanofi Aventis | Utilisation de la ferroquine dans le traitement ou la prevention du paludisme |
FR2951945B1 (fr) * | 2009-11-05 | 2013-08-09 | Sanofi Aventis | Composition pharmaceutique |
FR2961209B1 (fr) * | 2010-06-11 | 2013-03-01 | Sanofi Aventis | Procede de synthese de la ferroquine par amination reductrice convergente. |
FR2989588A1 (fr) * | 2012-04-19 | 2013-10-25 | Centre Nat Rech Scient | Composes pour la prevention ou le traitement des infections par des virus de la famille des flaviviridae |
BR112016009827B1 (pt) | 2013-11-08 | 2021-10-26 | Exthera Medical Corporation | Método in vitro para concentrar patógenos infecciosos presentes em uma amostra biológica obtida a partir de um indivíduo sob suspeita de estar infectado com os ditos patógenos, concentrador e kit |
CN105250295B (zh) * | 2014-07-07 | 2018-12-25 | 广州中医药大学科技产业园有限公司 | 一种联合用药物及其作为免疫调节剂的应用 |
US10512652B2 (en) | 2015-07-20 | 2019-12-24 | University Of Vermont And State Agricultural College | Use of cymanquine compounds as antimalarial agents |
CN107802755A (zh) * | 2017-11-08 | 2018-03-16 | 江西龙卿堂科技有限公司 | 一种具有防蚊防疟作用的青蒿软膏 |
KR102073961B1 (ko) * | 2018-11-16 | 2020-02-05 | (주)프론트바이오 | 메트포르민 및 페로센계 화합물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물 |
US20240207251A1 (en) * | 2021-04-26 | 2024-06-27 | Min Bo SHIM | Pharmaceutical composition containing artesunate or salt thereof and pyronaridine or salt thereof, for antipyresis, anti-inflammatory efficacy, anti-viral efficacy and treatment or prevention of covid-19, and method using same |
CN113952360B (zh) * | 2021-09-14 | 2023-03-10 | 上海交通大学 | 一种亚铁离子在治疗疟疾的药物中的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN166154B (es) * | 1987-05-08 | 1990-03-24 | Hoechst India | |
WO2005023304A2 (en) * | 2003-09-04 | 2005-03-17 | Cipla Limited | Antimalarial compositions and manufacturing process thereof |
-
2005
- 2005-04-20 FR FR0503932A patent/FR2884715B1/fr not_active Expired - Fee Related
-
2006
- 2006-04-17 PE PE2010000537A patent/PE20110119A1/es not_active Application Discontinuation
- 2006-04-17 PE PE2006000399A patent/PE20061314A1/es not_active Application Discontinuation
- 2006-04-18 CN CNA2006800130136A patent/CN101163470A/zh active Pending
- 2006-04-18 CA CA002605385A patent/CA2605385A1/fr not_active Abandoned
- 2006-04-18 UA UAA200712809A patent/UA96414C2/ru unknown
- 2006-04-18 ZA ZA200708800A patent/ZA200708800B/xx unknown
- 2006-04-18 MY MYPI20061772A patent/MY145581A/en unknown
- 2006-04-18 EP EP06743711A patent/EP1874293A1/fr not_active Withdrawn
- 2006-04-18 JP JP2008507122A patent/JP5148478B2/ja not_active Expired - Fee Related
- 2006-04-18 AP AP2007004211A patent/AP2782A/xx active
- 2006-04-18 BR BRPI0610851-2A patent/BRPI0610851A2/pt not_active IP Right Cessation
- 2006-04-18 CN CN201210369240XA patent/CN102836163A/zh active Pending
- 2006-04-18 SG SG201002562-5A patent/SG161270A1/en unknown
- 2006-04-18 KR KR1020077024076A patent/KR20080009088A/ko active IP Right Grant
- 2006-04-18 EA EA200702282A patent/EA012630B1/ru not_active IP Right Cessation
- 2006-04-18 AU AU2006238506A patent/AU2006238506B2/en not_active Ceased
- 2006-04-18 MX MX2007012645A patent/MX2007012645A/es active IP Right Grant
- 2006-04-18 WO PCT/FR2006/000842 patent/WO2006111647A1/fr active Application Filing
- 2006-04-18 NZ NZ562117A patent/NZ562117A/en not_active IP Right Cessation
- 2006-04-19 PA PA20068669801A patent/PA8669801A1/es unknown
- 2006-04-19 AR AR20060101538A patent/AR054253A1/es unknown
- 2006-04-20 GT GT200600157A patent/GT200600157A/es unknown
- 2006-04-20 HN HN2006015130A patent/HN2006015130A/es unknown
- 2006-04-20 TW TW095114167A patent/TWI387456B/zh not_active IP Right Cessation
- 2006-04-20 DO DO2006000092A patent/DOP2006000092A/es unknown
-
2007
- 2007-09-18 IL IL186048A patent/IL186048A0/en unknown
- 2007-09-21 TN TNP2007000359A patent/TNSN07359A1/en unknown
- 2007-10-08 CR CR9425A patent/CR9425A/es unknown
- 2007-10-18 US US11/874,377 patent/US20120258945A1/en not_active Abandoned
- 2007-11-16 NO NO20075920A patent/NO20075920L/no not_active Application Discontinuation
- 2007-11-19 MA MA30375A patent/MA29451B1/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20061314A1 (es) | Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo | |
UY30819A1 (es) | Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones | |
ES2916649T1 (es) | Composiciones y usos para el tratamiento de la esclerosis múltiple | |
CO6160321A2 (es) | Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo | |
PA8591701A1 (es) | Derivados de pirrolopirimidina | |
AR053162A1 (es) | Compuesto 5 - oxo - pirrolidin sustituido, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento del glaucoma. | |
UY30438A1 (es) | Derivados n-sustituidos de 5-halo-4-[2-alquil-1-sustituidos-1h-imidazol-5-il]pirimidin-2-amina, composiciones-procesos para su preparacion y usos | |
UY28923A1 (es) | Compuestos terapéuticos: piridina como estructura base | |
AR072261A1 (es) | Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos. | |
HN2001000037A (es) | Derivados de eteres de pirazol como agentes antiinflamatorios/analgesicos | |
AR077125A1 (es) | Combinaciones farmaceuticas utiles para tratar el vhc | |
TW200626158A (en) | Naphthaline derivatives | |
AR077138A1 (es) | Composiciones farmaceuticas utiles para tratar el vhc | |
AR054129A1 (es) | Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7 | |
AR109263A2 (es) | Composición que comprende moxidectina | |
AR077139A1 (es) | Composiciones farmaceuticas utiles para tratar el vch | |
UA97401C2 (ru) | Экструдат с улучшенной маскировкой вкуса | |
CL2023003662A1 (es) | Activadores de dimetoxifenilalquilamina de receptores de serotonina | |
DK2244703T3 (da) | Lægemiddel og fremstillingen og anvendelse deraf i behandlingen af smertefulde neuropatier | |
PE20090625A1 (es) | Composicion farmaceutica que contiene buprenorfina y nalmefeno | |
PE20130147A1 (es) | Combinacion farmaceutica de teobromina y un agente antitusivo no opioide | |
AR029666A1 (es) | Uso del (+) -alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-piperidinmetanol o su prodroga para la manufactura de un medicamento en el tratamiento de los sintomas de la demencia y de la psicosis inducida por dopamina | |
AR065139A1 (es) | Medicamento para el tratamiento de la endometriosis | |
CO5750041A1 (es) | Metodo para la fabricacion de un medicamento a base de una mezcla de acidos grasos poliinsaturados para la prevencion de infecciones respiratorias en infantes | |
CR8172A (es) | Saquinavir mesilato en forma de dosificacion farmaceutica oral |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |